The main aim of the study is to investigate whether orally administered oxytocin (24IU) could modulate females' neural and behavioral responses to affective stimuli including emotional faces and affective scenes.
Age range
18 Years – 30 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Changes in blood oxytocin concentrations after oral oxytocin
Timeframe: Before and 30 minutes after treatment
Effects of oral oxytocin on neural responses to emotional faces assessed by emotional faces processing task fMRI
Timeframe: 45 minutes after treatment
Effects of oral oxytocin on neural responses to affective scenes assessed by affective scenes processing task fMRI
Timeframe: 45 minutes after treatment
Effects of oral oxytocin on behavioral ratings of emotional faces stimuli
Timeframe: 45 minutes after treatment
Effects of oral oxytocin on behavioral ratings of affective scenes stimuli
Timeframe: 45 minutes after treatment